Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1819 1
1837 1
1842 1
1855 2
1857 1
1869 1
1871 1
1874 1
1877 2
1879 1
1882 1
1885 1
1887 1
1891 2
1892 1
1893 12
1895 2
1896 2
1897 1
1898 1
1901 1
1902 1
1905 2
1906 1
1907 3
1908 2
1911 1
1912 1
1913 3
1917 3
1918 1
1919 3
1920 1
1921 1
1922 1
1923 1
1924 3
1925 5
1926 3
1927 4
1928 13
1929 7
1930 5
1931 2
1932 4
1933 4
1934 8
1935 3
1936 3
1937 5
1938 6
1939 6
1940 4
1941 8
1942 6
1943 5
1944 2
1945 7
1946 13
1947 20
1948 13
1949 21
1950 28
1951 38
1952 29
1953 46
1954 37
1955 53
1956 90
1957 79
1958 84
1959 95
1960 86
1961 100
1962 80
1963 77
1964 97
1965 194
1966 178
1967 138
1968 96
1969 115
1970 105
1971 115
1972 127
1973 116
1974 160
1975 592
1976 763
1977 823
1978 833
1979 922
1980 892
1981 983
1982 1003
1983 1231
1984 1217
1985 1316
1986 1252
1987 1387
1988 1585
1989 1923
1990 2039
1991 2137
1992 2251
1993 2356
1994 2467
1995 2609
1996 2746
1997 2760
1998 2996
1999 3110
2000 3477
2001 3644
2002 3872
2003 4073
2004 4319
2005 4972
2006 5256
2007 5449
2008 5959
2009 6137
2010 6289
2011 6749
2012 7375
2013 7955
2014 9163
2015 10483
2016 12615
2017 12717
2018 12387
2019 11596
2020 11110
2021 11456
2022 10201
2023 9271
2024 3100

Text availability

Article attribute

Article type

Publication date

Search Results

211,694 results

Results by year

Filters applied: . Clear all
Page 1
B-Cell Lymphoma Producing IgM Anti-B Antibody: A Case Report.
Jiang F, Song T, Wang Y, Liu Z. Jiang F, et al. Front Med (Lausanne). 2022 May 16;9:904296. doi: 10.3389/fmed.2022.904296. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35652068 Free PMC article.
The patient was subsequently diagnosed with diffuse large B-cell lymphoma by lymph-node biopsy. His ABO blood group was initially typed as B on November 7, 2020. ...Although hemoglobin level did not greatly improve, indirect bilirubin level evidently decreased. Furt …
The patient was subsequently diagnosed with diffuse large B-cell lymphoma by lymph-node biopsy. His ABO blood group was initially typ …
Assessing Consistency in Single-Case A-B-A-B Phase Designs.
Tanious R, De TK, Michiels B, Van den Noortgate W, Onghena P. Tanious R, et al. Behav Modif. 2020 Jul;44(4):518-551. doi: 10.1177/0145445519837726. Epub 2019 Mar 31. Behav Modif. 2020. PMID: 30931585
In the current article, we extend the existing literature by introducing two methods for quantifying consistency in single-case A-B-A-B phase designs. The first method assesses the consistency of data patterns across phases implementing the same condition, ca …
In the current article, we extend the existing literature by introducing two methods for quantifying consistency in single-case A- …
CD5 positive B-ALL, a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature.
Staley EM, Feldman AZ, Koenig RG, Hill B. Staley EM, et al. Pediatr Blood Cancer. 2019 Jan;66(1):e27484. doi: 10.1002/pbc.27484. Epub 2018 Sep 30. Pediatr Blood Cancer. 2019. PMID: 30270496 Review.
There are six detailed case reports in the literature, with only 16 cases described. Case series analyzing the frequency of aberrant B-ALL immunophenotypes suggest that this variant may occur in as little as 2-4.5% of all B-ALL cases, with one series h …
There are six detailed case reports in the literature, with only 16 cases described. Case series analyzing the frequency of ab …
Polymyxin B-induced rhabdomyolysis: A case report.
Ni M, Meng X, Wang L, Zhao Y, Yu M, Shi S. Ni M, et al. Medicine (Baltimore). 2020 Oct 23;99(43):e22924. doi: 10.1097/MD.0000000000022924. Medicine (Baltimore). 2020. PMID: 33120846 Free PMC article.
In this study, we firstly report a case of polymyxin B-induced rhabdomyolysis during antiinfection therapy. ...LESSONS: Here, we report the first reported case of rhabdomyolysis induced by polymyxin B administration. The awareness of rare adverse react …
In this study, we firstly report a case of polymyxin B-induced rhabdomyolysis during antiinfection therapy. ...LESSONS: Here, …
Validity of hepatitis B and hepatitis C case definitions.
Dakic Z, Duric P, Fabri M, O'May F. Dakic Z, et al. J Infect Public Health. 2019 Jul-Aug;12(4):516-521. doi: 10.1016/j.jiph.2019.01.061. Epub 2019 Feb 13. J Infect Public Health. 2019. PMID: 30772265 Free article.
The study evaluated the sensitivity and specificity of hepatitis B and hepatitis C case definitions, current at the time of data collection, recommended by the European Commission (EC) and the Centers for Disease Prevention and Control (CDC). ...RESULTS: EC 2008 and …
The study evaluated the sensitivity and specificity of hepatitis B and hepatitis C case definitions, current at the time of da …
Antineutrophil cytoplasmic antibodies (ANCA)-positive patient with infective endocarditis and chronic hepatitis B virus: a case report and review of the literature.
Zhang Q, Shi B, Zeng H. Zhang Q, et al. J Med Case Rep. 2020 Jul 6;14(1):90. doi: 10.1186/s13256-020-02373-1. J Med Case Rep. 2020. PMID: 32624005 Free PMC article. Review.
CASE PRESENTATION: We report a case of a 46-year-old Han Chinese man with untreated chronic hepatitis B virus infection who featured proteinase-3 antineutrophil cytoplasmic antibody positivity while hospitalized with infective endocarditis. ...CONCLUSIONS: Th
CASE PRESENTATION: We report a case of a 46-year-old Han Chinese man with untreated chronic hepatitis B virus infection
Association of acute hepatitis B and acute myopathy: a case report.
Zangeneh M, Mesgarian M, Khosravani-Nezhad Y. Zangeneh M, et al. J Med Case Rep. 2022 Apr 9;16(1):143. doi: 10.1186/s13256-022-03330-w. J Med Case Rep. 2022. PMID: 35395817 Free PMC article.
BACKGROUND: Hepatitis B virus infection is a global public health problem. Although hepatitis B virus primarily affects hepatocytes, it sometimes develops disease manifestations outside the liver, such as myopathy, which is commonly caused by chronic hepatitis B
BACKGROUND: Hepatitis B virus infection is a global public health problem. Although hepatitis B virus primarily affects hepato …
Intravascular diffuse large B-cell lymphoma with acquired ichthyosis: A case report.
Ridha Z, Zargham H, Chergui M, Netchiporouk E. Ridha Z, et al. SAGE Open Med Case Rep. 2023 Mar 30;11:2050313X231163630. doi: 10.1177/2050313X231163630. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37025247 Free PMC article.
Intravascular diffuse large B-cell lymphoma is an exceedingly rare subtype of B-cell lymphomas. ...This case highlights the importance of a prompt dermatology consultation in the diagnosis of intravascular diffuse large B-cell lymphoma. ...
Intravascular diffuse large B-cell lymphoma is an exceedingly rare subtype of B-cell lymphomas. ...This case highlights …
Use of amphotericin B during pregnancy: case report and review.
Dean JL, Wolf JE, Ranzini AC, Laughlin MA. Dean JL, et al. Clin Infect Dis. 1994 Mar;18(3):364-8. doi: 10.1093/clinids/18.3.364. Clin Infect Dis. 1994. PMID: 8011817 Review.
We present a case of fungemia due to Torulopsis glabrata that occurred during pregnancy and that was treated with amphotericin B. ...In the latter case, placental tissue may have served as the reservoir from which amphotericin B was slowly released int …
We present a case of fungemia due to Torulopsis glabrata that occurred during pregnancy and that was treated with amphotericin B
Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia.
Nagy ZF, Ferenczi K, Istenes I, Eid H, Bödör C, Timár B, Demeter J. Nagy ZF, et al. Pathol Oncol Res. 2022 Apr 29;28:1610338. doi: 10.3389/pore.2022.1610338. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35570843 Free PMC article.
It has been proposed that HCL patients are at risk of developing a secondary malignancy, with a marked likelihood of the development of other hematologic malignancies including Hodgkin lymphoma and high-grade non-Hodgkin lymphomas. Here, we present the case of two patients …
It has been proposed that HCL patients are at risk of developing a secondary malignancy, with a marked likelihood of the development of othe …
211,694 results
You have reached the last available page of results. Please see the User Guide for more information.